MENU
ZYME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Zymeworks (ZYME) Ownership - Who owns Zymeworks?
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
108 Patriot Drive
Phone
+1 302 274-8744
Employees
277
Web
https://www.zymeworks.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
871.1M
P/E Ratio
N/A
Total Cash
225.78M
Projected Growth
N/A
Total Debt
18.51M
Revenue
76.3M
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
3.24
Total Debt/Equity
N/A
Revenue/Share
1.01 USD as % of share price
Fundamentals
ZYME
Capitalization
871M
P/E Ratio
N/A
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash
226M
Total Cash/Share
3.24
Total Debt
18.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.01%
Revenue
76.3M
ROE
N/A
Book Value
339M
P/B Ratio
2.57
Cash Flow
N/A
Earnings
-1.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.02B
Current Ratio
3.40
Current Revenue Per Employee
108500.00
Dividends Per Share - Security
N/A
EBITDA
-108.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-23.51
Shares Held By Institutions
1.21B
Shares Outstanding - Current
69.6M
Total Liabilities
124M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-14.481
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company for cancer & autoimmune treatment
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
108 Patriot Drive
Phone
+1 302 274-8744
Employees
277
Web
https://www.zymeworks.com